Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (141-150 of 241) with videos related to

Pageof 25
Sort By:
Drug Metabolism and Pharmacokinetics|March 21, 2006
Novel single nucleotide polymorphism of UGT1A7 gene in JapaneseKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
International Journal of Clinical Oncology|April 24, 2013
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemiaTakashi Shibata, Yosuke Minami, Ayako Mitsuma, et al.
Oncology Letters|December 2, 2015
FOLFIRINOX-induced reversible dysarthria: A case report and review of previous casesAyumu Matsuoka, Osamu Maeda, Megumi Inada-Inoue, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2012
Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancerSachi Morita, Keisuke Uehara, Goro Nakayama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 27, 2005
Gefitinib (Iressa) inhibits the CYP3A4-mediated formation of 7-ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin but activates that of 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino]carbonyloxycamptothecin from irinotecanKen-Ichi Fujita, Yuichi Ando, Masaru Narabayashi, et al.
Drug Metabolism and Pharmacokinetics|March 21, 2006
Novel single nucleotide polymorphism of UGT1A9 gene in JapaneseKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2007
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancerKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
BMC Cancer|December 18, 2014
Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotypeYuji Miura, Chiyo K Imamura, Koya Fukunaga, et al.
Nagoya Journal of Medical Science|April 21, 2012
Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroidsAyako Mitsuma, Masataka Sawaki, Takashi Shibata, et al.
International Cancer Conference Journal|January 8, 2024
Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcomaYao Liang, Osamu Maeda, Tomoya Shimokata, et al.
Pageof 25

Showing results (141-150 of 241) with videos related to

Sort By:
Pageof 25
Drug Metabolism and Pharmacokinetics|March 21, 2006
Novel single nucleotide polymorphism of UGT1A7 gene in JapaneseKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
International Journal of Clinical Oncology|April 24, 2013
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemiaTakashi Shibata, Yosuke Minami, Ayako Mitsuma, et al.
Oncology Letters|December 2, 2015
FOLFIRINOX-induced reversible dysarthria: A case report and review of previous casesAyumu Matsuoka, Osamu Maeda, Megumi Inada-Inoue, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2012
Association between bevacizumab-related hypertension and vascular endothelial growth factor (VEGF) gene polymorphisms in Japanese patients with metastatic colorectal cancerSachi Morita, Keisuke Uehara, Goro Nakayama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 27, 2005
Gefitinib (Iressa) inhibits the CYP3A4-mediated formation of 7-ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin but activates that of 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino]carbonyloxycamptothecin from irinotecanKen-Ichi Fujita, Yuichi Ando, Masaru Narabayashi, et al.
Drug Metabolism and Pharmacokinetics|March 21, 2006
Novel single nucleotide polymorphism of UGT1A9 gene in JapaneseKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
Cancer Chemotherapy and Pharmacology|April 5, 2007
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancerKen-ichi Fujita, Yuichi Ando, Fumio Nagashima, et al.
BMC Cancer|December 18, 2014
Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotypeYuji Miura, Chiyo K Imamura, Koya Fukunaga, et al.
Nagoya Journal of Medical Science|April 21, 2012
Extravasation of pegylated-liposomal doxorubicin: favorable outcome after immediate subcutaneous administration of corticosteroidsAyako Mitsuma, Masataka Sawaki, Takashi Shibata, et al.
International Cancer Conference Journal|January 8, 2024
Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcomaYao Liang, Osamu Maeda, Tomoya Shimokata, et al.
Pageof 25